Literature DB >> 3180139

Immunotherapy of cancer: experimental approach with activated macrophages proliferating in culture.

J Bartholeyns1, Y Lombard, S Dumont, D Hartmann, M Chokry, J Giaimis, S Kaufmann, P Poindron.   

Abstract

Murine macrophages isolated from the peritoneal cavity or from the lung were continuously grown and expanded in vitro on a confluent layer of "mesothelial or endothelial" feeding cells. These cell lines could be obtained from C57B16 or BalbC mice and were nontumorogenic in nude mice. The macrophages were characterized by their capacity to phagocytose yeasts and by the presence of nonspecific esterases, of Fc receptors, and of specific antigens (MAC1 ...). In vitro, these macrophages were fully activated and were tumoricidal against different tumor cell lines. In vivo, adoptive transfer of the expanded macrophages to mice bearing EMT6 sarcoma or 3LL metastasizing carcinoma inhibited the growth of the primary tumors and the development of metastases. Local injection in the vicinity of the primary tumor and i.v. transplantation were effective. The adoptive transfer of expanded macrophages could lead to a new kind of immunotherapy of neoplastic diseases combining selective amplification with effective activation of macrophages as key effector cells.

Entities:  

Mesh:

Year:  1988        PMID: 3180139

Source DB:  PubMed          Journal:  Cancer Detect Prev        ISSN: 0361-090X


  2 in total

1.  Local immunostimulation induced by intravesical administration of autologous interferon-gamma-activated macrophages in patients with superficial bladder cancer.

Authors:  F Pagès; S Lebel-Binay; A Vieillefond; L Deneux; M Cambillau; O Soubrane; B Debré; D Tardy; J-L Romet Lemonne; J-P Abastado; W-H Fridman; N Thiounn
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

2.  Cancer immunotherapy: potential involvement of mediators.

Authors:  S Ben-Efraim
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.